← Open Payments lookup

EVAN KOESLER: Open Payments

NPI 1780065755 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$670 in 30 payments from 11 companies in 2025. Trend: 2023 $140 · 2024 $25 · 2025 $670

Food & beverage: $670
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$192
Novartis Pharmaceuticals Corporation5$106
Takeda Pharmaceuticals U.S.A., Inc.4$100
Regeneron Healthcare Solutions, Inc.5$86
Amgen Inc.3$50
GENZYME CORPORATION1$30
Grifols USA, LLC1$26
ARS Pharmaceuticals Operations, Inc.1$23
Optinose US, Inc.1$21
Organon LLC2$19

Products named: DUPIXENT, TEZSPIRE, FASENRA, CUVITRU, XOLAIR, Xembify, AIRSUPRA, NEFFY.

Industry payments across TX — which companies pay providers there.